Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An adenocarcinoma arising from Barrett metaplastic epithelium in the esophagus. There is evidence supporting the idea that the Barrett adenocarcinomas develop through a stepwise progression through intestinal metaplastic epithelium to epithelial dysplasia to malignancy. Adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. In terms of grading, they are well or moderately differentiated adenocarcinomas. -- 2002
Biomarker and diagnostic research for Barrett adenocarcinoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
12 publications have been identified in PubMed for Barrett adenocarcinoma. Research spans Basic Science / Preclinical (33%), Diagnostic / Biomarker (17%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 4 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Common questions about Barrett adenocarcinoma
Testing and diagnosis research |
2 |
17% |
Patient case studies | 2 | 17% |
Disease patterns and progression | 2 | 17% |
Research summaries | 1 | 8% |
Clinical study results | 1 | 8% |
Tvaradze G (2026). [PMID: 42276130](https://pubmed.ncbi.nlm.nih.gov/42276130/). *Endoscopy*. [Clinical Trial Publication]
Ishibashi F (2026). [PMID: 41638901](https://pubmed.ncbi.nlm.nih.gov/41638901/). *Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society*. [Case Report / Case Series]
Asano N (2026). [PMID: 40952946](https://pubmed.ncbi.nlm.nih.gov/40952946/). *Digestion*. [Review / Meta-Analysis]
de Oliveira THA (2025). [PMID: 40200065](https://pubmed.ncbi.nlm.nih.gov/40200065/). *British journal of cancer*. [Epidemiology / Natural History]
Pljakic E (2025). [PMID: 41301712](https://pubmed.ncbi.nlm.nih.gov/41301712/). *Biomedicines*. [Epidemiology / Natural History]
Miyoshi J (2025). [PMID: 39562048](https://pubmed.ncbi.nlm.nih.gov/39562048/). *Gut*. [Diagnostic / Biomarker]
Shah SC (2025). [PMID: 40569319](https://pubmed.ncbi.nlm.nih.gov/40569319/). *Clinical and translational gastroenterology*. [Basic Science / Preclinical]
Abe H (2025). [PMID: 39663311](https://pubmed.ncbi.nlm.nih.gov/39663311/). *Gastric Cancer*. [Basic Science / Preclinical]
Greer KB (2025). [PMID: 38989889](https://pubmed.ncbi.nlm.nih.gov/38989889/). *Am J Gastroenterol*. [Diagnostic / Biomarker]
Milne JV (2024). [PMID: 38721276](https://pubmed.ncbi.nlm.nih.gov/38721276/). *Frontiers in molecular biosciences*. [Basic Science / Preclinical]